🔎 Trials Near Me

Home › Steatotic Liver Disease › California › San Francisco

Steatotic Liver Disease clinical trials in San Francisco, CA

5 studies for Steatotic Liver Disease are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

RecruitingPhase 2
  • UCSF/Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco
  • UCSF Medical Center, San Francisco
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT05832229

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

RecruitingPhase 3
  • Quest Clinical Research, San Francisco
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

RecruitingPhase 3
  • Akero Clinical Study Site, San Francisco
  • Akero Clinical Study Site, San Francisco
Ages 18 to 80 · All sexes · Updated Sep 21, 2026 · NCT06528314

Bicalutamide Therapy in Young Women With NAFLD and PCOS

RecruitingPhase 1
  • University of California San Francisco, San Francisco
Ages 18 to 42 · Women · Updated May 29, 2026 · NCT05979389

Androgens and NAFLD Longitudinal Cohort Study

RecruitingObservational study
  • University of California San Francisco, San Francisco
Ages 18 to 42 · Women · Updated Apr 13, 2026 · NCT06124261

About Steatotic Liver Disease

Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.

More about Steatotic Liver Disease on MedlinePlus

Steatotic Liver Disease trials in other cities

Other studies in San Francisco

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.